1. Home
  2. MPA vs RFL Comparison

MPA vs RFL Comparison

Compare MPA & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniYield Pennsylvania Quality Fund

MPA

Blackrock MuniYield Pennsylvania Quality Fund

HOLD

Current Price

$9.70

Market Cap

142.3M

Sector

Finance

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$2.11

Market Cap

133.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPA
RFL
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Real Estate
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
142.3M
133.1M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
MPA
RFL
Price
$9.70
$2.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
38.4K
★ 114.9K
Earning Date
01-01-0001
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 28.28
EPS
★ N/A
N/A
Revenue
N/A
★ $917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 43.96
52 Week Low
$9.68
$1.12
52 Week High
$11.87
$3.96

Technical Indicators

Market Signals
Indicator
MPA
RFL
Relative Strength Index (RSI) 11.94 44.55
Support Level N/A $1.22
Resistance Level $11.49 $2.16
Average True Range (ATR) 0.13 0.17
MACD -0.05 -0.02
Stochastic Oscillator 1.63 26.77

Price Performance

Historical Comparison
MPA
RFL

About MPA Blackrock MuniYield Pennsylvania Quality Fund

Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with an investment objective to provide shareholders with as high a level of current income exempt from U.S. federal and Pennsylvania income taxes as is consistent with its investment policies and prudent investment management. The Fund seeks to achieve its investment objective by investing, as a fundamental policy, at least 80% of an aggregate of the Fund's net assets and the proceeds of any borrowings for investment purposes, in a portfolio of municipal obligations issued by or on behalf of the State of Pennsylvania, its political subdivisions, agencies, and instrumentalities and by other qualifying issuers.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: